| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |